fda compounded semaglutide news The has approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection, Wegovy HD, for weight loss and long-term weight maintenance in certain adult patients—in just 54 days from filing FDA moves to stop compounding

To measure the severity of your sleep apnea, healthcare providers calculate the average number of breathing disruptions you experience per hour of sleepalso known as your AHI score

These limits reduce misuse but ensure that eligible members continue to receive treatment

[2] [3] However, reduced effectiveness can have multiple causes, and patients should consult their healthcare provider rather than simply replacing the medication

Serious risks (uncommon but important) Gallbladder problems (such as gallstones): Watch for right upper belly pain, fever, or jaundice

Learn more about GLP-1s here:

More than 75% of prior authorizations submitted were not being requested for the FDA approved indication